- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7042 - Compounds having saccharide radicals and heterocyclic rings
Patent holdings for IPC class A61K 31/7042
Total number of patents in this class: 503
10-year publication summary
|
21
|
33
|
40
|
32
|
33
|
31
|
49
|
36
|
29
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim Vetmedica GmbH | 1274 |
34 |
| Mirum Pharmaceuticals, Inc. | 110 |
15 |
| Janssen Pharmaceutica N.V. | 3160 |
13 |
| The Regents of the University of California | 20842 |
10 |
| Shire Human Genetic Therapies, Inc. | 190 |
8 |
| California Institute of Technology | 4037 |
7 |
| Boyce Thompson Institute for Plant Research | 27 |
7 |
| Washington University | 1757 |
7 |
| Chinook Therapeutics, Inc. | 39 |
7 |
| The Board of Trustees of the University of Illinois | 2753 |
6 |
| AstraZeneca AB | 2824 |
5 |
| Lexicon Pharmaceuticals, Inc. | 194 |
5 |
| Microbion Corporation | 33 |
5 |
| Mitsubishi Tanabe Pharma Corporation | 398 |
5 |
| Sapiotec GmbH | 18 |
5 |
| Curology, Inc. | 65 |
5 |
| President and Fellows of Harvard College | 6110 |
4 |
| Vertex Pharmaceuticals Incorporated | 1575 |
4 |
| Albireo AB | 173 |
4 |
| Inventiva | 106 |
4 |
| Other owners | 343 |